ExCEED Trial #2017-18
Research payments
$576,631
Through program year 2025, $576,631 in research payments was reported against ExCEED Trial #2017-18, across 307 payments, paid by Edwards Lifesciences Corporation.
- Paid by
- Edwards Lifesciences Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $69,328 | 46 |
| 2024 | Research | $125,106 | 75 |
| 2023 | Research | $88,404 | 51 |
| 2022 | Research | $121,321 | 58 |
| 2021 | Research | $172,472 | 77 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Robert Stoler Dallas, TX Named on 27 payments
- Stephen Bailey Pittsburgh, PA Named on 22 payments
- Alan Zajarias Saint Louis, MO Named on 19 payments
- Philippe Genereux New York, NY Named on 14 payments
- Timothy Mixon Temple, TX Named on 13 payments
- William Oneill Detroit, MI Named on 10 payments
- Evelio Rodriguez Nashville, TN Named on 9 payments
- Susheel Kodali New York, NY Named on 9 payments
- Peter Tadros Kansas City, KS Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.